Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Oct;8(5):501-506.
doi: 10.21037/tau.2019.08.24.

An open-label, single-arm pilot study to evaluate the efficacy of daily low dose tadalafil on depression in patients with erectile dysfunction

Jin Bong Choi  1 , Kang Jun Cho  1 , Joon Chul Kim  1 , Chi-Un Pae  2 , Jun Sung Koh  1
Affiliations

An open-label, single-arm pilot study to evaluate the efficacy of daily low dose tadalafil on depression in patients with erectile dysfunction

Jin Bong Choi et al. Transl Androl Urol. 2019 Oct.

Abstract

Background: Many studies have reported not only that depression and antidepressant medications can cause erectile dysfunction (ED), but also that having ED may increase the risk of depression. We investigated the effect of a daily low dose of a phosphodiesterase (PDE) type 5 inhibitor (tadalafil, 5 mg) on depression and levels of brain-derived neurotrophic factor (BDNF) in patients with ED.

Methods: Ten male patients with at least a 3-month history of ED [International Index of Erectile Function (IIEF)-5 score ≤21] and depression [the Korean version of the Patient Health Questionnaire (PHQ)-9 score ≥5] were analyzed in this study. The subjects were prescribed a low dose of a PDE5 inhibitor (tadalafil 5 mg) once daily for 8 weeks. The survey questionnaires were performed using the PHQ-15 and the PHQ-9 before and after administration of 8 weeks of tadalafil. Blood samples used for measuring serum BDNF levels were taken and measured at baseline and after 8 weeks of treatment.

Results: The mean changes in the PHQ-9 and PHQ-15 scores were 3.60±3.27 and 2.00±2.98, respectively. Analyses of the mean changes in the PHQ-9 scores revealed that the depressive symptoms of the subjects were significantly improved after administration of eight weeks of tadalafil (P<0.05). And, there was also a statistically significant increase in the PHQ-15 scores (P<0.05). Serum levels of BDNF were higher after tadalafil treatment compared to before treatment; however, this difference was not statistically significant.

Conclusions: The results of this prospective, clinical study suggest that daily low dose tadalafil may have a potential role in the treatment of depression in patients with ED.

Keywords: Brain-derived neurotrophic factor (BDNF); depression; phosphodiesterase (PDE).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The study was sponsored by Hanmi Pharm Co., Ltd.

Figures

Figure 1
Figure 1
Mean changes in PHQ-9 and PHQ-15 scores at baseline, and after 4 and 8 weeks. *, P<0.05 compared with baseline. PHQ, Patient Health Questionnaire.
See this image and copyright information in PMC

Comment in

References

    1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA 1999;281:537-44. 10.1001/jama.281.6.537 - DOI - PubMed
    1. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998;13:159-66. 10.1046/j.1525-1497.1998.00050.x - DOI - PMC - PubMed
    1. Liu Q, Zhang Y, Wang J, et al. Erectile Dysfunction and Depression: A Systematic Review and Meta-Analysis. J Sex Med 2018;15:1073-82. 10.1016/j.jsxm.2018.05.016 - DOI - PubMed
    1. Shiri R, Koskimaki J, Tammela TL, et al. Bidirectional relationship between depression and erectile dysfunction. J Urol 2007;177:669-73. 10.1016/j.juro.2006.09.030 - DOI - PubMed
    1. Lemogne C, Ledru F, Bonierbale M, et al. Erectile dysfunction and depressive mood in men with coronary heart disease. Int J Cardiol 2010;138:277-80. 10.1016/j.ijcard.2008.08.017 - DOI - PubMed